authors
- Chen, Kaylie
- Chen, Johnson
- Smith, Emily
- Mathani, Prerna
- Longman, Randy
- Lukin, Dana Jeremy
- Scherl, Ellen J
- Gerber, Juliette
- Battat, Robert
Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.
Academic Article
Overview
publication date
- November 24, 2022
published in
- Inflammatory bowel diseases Journal
Research
keywords
- Crohn Disease
- Ustekinumab
Identity
Digital Object Identifier (DOI)
- 10.1093/ibd/izac236
PubMed ID
- 36421052